HealthWatch LTD (HealthWatch), a global leading medical device company continues to develop its reach and global footprint and announced today that it has entered into a strategic partnership and signed a Memorandum of Understanding with Nuveos Tech LLP (Nuveos), an Indian technology innovation driven medical device distributor. This partnership is just one of many global supply arrangements that HealthWatch has in development after the ongoing joint activity with Canadian company CardioComm. As part of the agreement, Nuveos will commence a large-scale clinical trial at the H. N. Reliance Foundation Hospital, one of the leading and highly respected hospital chains in India, with world-class healthcare services and cutting-edge technology. This clinical trial, run by Dr. Manoj Mashru, will lead to a future exclusive distribution agreement between HealthWatch and Nuveos.
“We will continue to invest in strategic alliances with well-positioned business partners to maintain our position as a front-runner in the smart clothes wearables industry globally,” says Dr. Gary Sagiv, CCO & EVP of HealthWatch. “This partnership with Nuveos demonstrates HealthWatch’s commitment and ability to be a global player in the rapidly expanding wearables global ecosystem. During the past decade, the Indian medical device market has proven to be the first to adopt innovative technologies, becoming a true global opinion leader. As HealthWatch’s main goal is to regain quality of life of cardiac patients, we believe that this step will contribute to the progress of the national healthcare system in India and to the well-being of patients. The current Indian economy is set to rapidly expand, which sets the HealthWatch-Nuveos strategic partnership in an industry leading position to supply local demand.”
According to Mr. Israel Schreiber, CEO of HealthWatch, “We are extremely excited about this joint venture in the Indian economy. Focusing on Israel as a source of innovative digital health tech products and solutions, Nuveos’ trust in HealthWatch is highly appreciated, being just the first step of a long-lasting relationship with Nuveos in particular and the Indian market, in general. The past few years’ tightening political and economic ties between Israel and India have made this collaboration possible. Nuveos were chosen out of many other distributors due to their professionalism, experience and enthusiasm to improve the medical system in India”.
HealthWatch was founded in 2010 in Kfar Saba, Israel, and has developed the Master Caution®, the first and only 3-12 lead ECG smart digital garment that is CE/FDA-cleared. It advocates a full management solution for the purpose of transforming healthcare, offering a digital health platform and virtual medical care intertwined with the Medical Internet-of-Things. This non-lifestyle changing disruptive technology, based on wearable textile-electrodes and heart-sensing sensors and technologies, contains a myriad of accurate digital health diagnostic services including mobile cardiac telemetry, patient monitoring tele-health services and other services that allow for in-home medical services. The Master Caution®’s continuous monitoring solutions assist clinicians in remotely monitoring their elderly or bed-ridden patients, while being alerted to cardiac events such as ischemia and arrhythmias in near real-time, securing personal health around-the-clock for improved patient safety.
FOR FURTHER INFORMATION PLEASE CONTACT:
Moran Faibish, Marketing Manager – [email protected]
About Nuveos Tech LLP
Nuveos Tech LLP, a Government of India recognized startup, is a technology and innovation driven medical device company providing affordable, accessible, quality healthcare service throughout India. Nuveos are a distribution, importing and marketing startup, forming strategic partnerships with medical devices company globally. The company’s goal is to bridge the gap between innovators and consumers – whether healthcare providers or patients.
FOR FURTHER INFORMATION PLEASE CONTACT:
Harit Agrawal, Managing Director – [email protected]